Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Rouault-Pierre

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Leukemia|February 2, 2020
Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartmentAurélie Caye, Kevin Rouault-Pierre, Marion Strullu, et al.
Research Square|April 24, 2023
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan Ling, Jian Zhang, et al.
Science Translational Medicine|March 1, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in <i>SF3B1</i>-mutated myelodysplasiaSyed A Mian, Céline Philippe, Eleni Maniati, et al.
Nature Communications|April 14, 2023
Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell deathKeith Woodley, Laura S Dillingh, George Giotopoulos, et al.
Blood Advances|May 17, 2024
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan P Ling, Jian Zhang, et al.
Nature Communications|June 19, 2026
PERK orchestrates an endoplasmic reticulum stress alternative splicing program via CLK1/SRSF1Céline Philippe, Shoshana Burke, Arantxa Carrasco-Leon, et al.
Leukemia|April 9, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genesFadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen, et al.
Nature Communications|December 9, 2022
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromesNerea Berastegui, Marina Ainciburu, Juan P Romero, et al.
Leukemia|August 26, 2024
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Leukemia|February 2, 2020
Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartmentAurélie Caye, Kevin Rouault-Pierre, Marion Strullu, et al.
Research Square|April 24, 2023
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan Ling, Jian Zhang, et al.
Science Translational Medicine|March 1, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in <i>SF3B1</i>-mutated myelodysplasiaSyed A Mian, Céline Philippe, Eleni Maniati, et al.
Nature Communications|April 14, 2023
Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell deathKeith Woodley, Laura S Dillingh, George Giotopoulos, et al.
Blood Advances|May 17, 2024
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan P Ling, Jian Zhang, et al.
Nature Communications|June 19, 2026
PERK orchestrates an endoplasmic reticulum stress alternative splicing program via CLK1/SRSF1Céline Philippe, Shoshana Burke, Arantxa Carrasco-Leon, et al.
Leukemia|April 9, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genesFadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen, et al.
Nature Communications|December 9, 2022
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromesNerea Berastegui, Marina Ainciburu, Juan P Romero, et al.
Leukemia|August 26, 2024
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.
Pageof 4